| __timestamp | Genmab A/S | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 505679000 | 180753000 |
| Thursday, January 1, 2015 | 487656000 | 224193000 |
| Friday, January 1, 2016 | 660876000 | 197617000 |
| Sunday, January 1, 2017 | 874278000 | 288320000 |
| Monday, January 1, 2018 | 1431159000 | 240661000 |
| Tuesday, January 1, 2019 | 2386000000 | 276018000 |
| Wednesday, January 1, 2020 | 3137000000 | 294216000 |
| Friday, January 1, 2021 | 4181000000 | 354881000 |
| Saturday, January 1, 2022 | 5562000000 | 361140000 |
| Sunday, January 1, 2023 | 7630000000 | 330551000 |
| Monday, January 1, 2024 | 9748000000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Genmab A/S has demonstrated a remarkable commitment to innovation, with its R&D expenses surging by over 1,400% from 2014 to 2023. This Danish biotech powerhouse has consistently prioritized groundbreaking research, culminating in a staggering 7.63 billion in R&D spending by 2023.
In contrast, Grifols, S.A., a Spanish pharmaceutical giant, has maintained a steady yet modest growth in R&D investments, increasing by approximately 83% over the same period. While Grifols' focus remains on its core competencies, the disparity in R&D spending highlights Genmab's aggressive pursuit of cutting-edge therapies.
This comparison underscores the diverse strategies within the biotech sector, where innovation and strategic investments shape the future of healthcare.
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Genmab A/S
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Analyzing R&D Budgets: Genmab A/S vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Pharming Group N.V. or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Grifols, S.A. vs Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and Corcept Therapeutics Incorporated
Research and Development Investment: Grifols, S.A. vs HUTCHMED (China) Limited
Grifols, S.A. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated